Weighing the options for obesity meds

When lifestyle interventions alone are insufficient to help patients lose weight, pharmacotherapy may be indicated. This review covers what to assess before prescribing one of the 5 US Food and Drug Administration-approved medications for chronic weight loss: orlistat, lorcaserin, phentermine/topiramate, bupropion/naltrexone, and liraglutide. To read the full article, go to Clinician Reviews:  http://www.clinicianreviews.com/specialty-focus/endocrinology-metabolism/article/weighing-the-options-for-obesity-meds/ed4de5e0a96247503e79f467f2598ab3.html.

When lifestyle interventions alone are insufficient to help patients lose weight, pharmacotherapy may be indicated. This review covers what to assess before prescribing one of the 5 US Food and Drug Administration-approved medications for chronic weight loss: orlistat, lorcaserin, phentermine/topiramate, bupropion/naltrexone, and liraglutide. To read the full article, go to Clinician Reviews:  http://www.clinicianreviews.com/specialty-focus/endocrinology-metabolism/article/weighing-the-options-for-obesity-meds/ed4de5e0a96247503e79f467f2598ab3.html.

When lifestyle interventions alone are insufficient to help patients lose weight, pharmacotherapy may be indicated. This review covers what to assess before prescribing one of the 5 US Food and Drug Administration-approved medications for chronic weight loss: orlistat, lorcaserin, phentermine/topiramate, bupropion/naltrexone, and liraglutide. To read the full article, go to Clinician Reviews:  http://www.clinicianreviews.com/specialty-focus/endocrinology-metabolism/article/weighing-the-options-for-obesity-meds/ed4de5e0a96247503e79f467f2598ab3.html.